Differentiation of bovine from porcine gelatines using polyclonal anti-peptide antibodies in indirect and competitive indirect ELISA

Journal of Pharmaceutical and Biomedical Analysis

Volumn 39, Issue 3-4, 2005, Pages 418-424

  Venien, A ^a   Levieux, D ^a  

^a CEMAGREF   (France)

Author keywords

Bovine; Bovine spongiform encephalopathy; BSE; Collagen; ELISA; Gelatine; Peptides; Porcine

Indexed keywords

COLLAGEN; GELATIN; PEPTIDE ANTIBODY;

ACIDITY; ALKALINITY; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ARTICLE; BONE; CONTROLLED STUDY; COW; DILUTION; DRUG BLOOD LEVEL; DRUG INDUSTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNIZATION; LABORATORY; NONHUMAN; PRIORITY JOURNAL; RABBIT; SKIN; SWINE;

ANIMALS; ANTIBODIES; BINDING, COMPETITIVE; CATTLE; COLLAGEN; COLLAGEN TYPE I; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INDUSTRY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GELATIN; PEPTIDES; SPECIES SPECIFICITY; SWINE; TYROSINE;

EID: 23944458366     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2005.04.013     Document Type: Article

References (16)

1. M. Nemati, M. Oveisi, H. Abdollahi, and O. Sabzevari J. Pharm. Biomed. Anal. 34 2004 485 492
2. S. Hidaka, and S.Y. Liu J. Food Compos. Anal. 16 2003 477 483
3. A. Paraf, and G. Peltre Immunoassays in Food and Agriculture 1991 Kluwer Academic Publishers Dordrecht
4. D. Levieux, and A. Levieux J. Immunoassay Immunochem. 22 2001 127 145
5. A. Levieux, V. Rivera, and D. Levieux J. Immunoassay Immunochem. 22 2001 323 336
6. V. Rivera, A. Levieux, and D. Levieux J. Pharm. Biomed. Anal. 29 2002 431 441
7. V. Rivera, A. Levieux, and D. Levieux J. Pharm. Biomed. Anal. 29 2002 443 458
8. K. Hofmann, K. Fisher, E. Mueller, and W. Babel Nahrung 43 1999 406 409
9. M. Sela, and R. Arnon Biochem. J. 75 1960 91 102
10. S. Avrameas, and T. Ternynck Immunochemistry 6 1969 53 66
11. J. Vaitukaitis, J.B. Robbins, E. Nieschlag, and G.T. Ross J. Clin. Endocrinol. 33 1971 988 991
12. E.C. (European Commission), Report on the Current State of Knowledge on the TSE Infectivity Clearance Capacity of Various Gelatine Production Processes, 2002 (www.europa.eu.int ).
13. E.C. (European Commission), Scientific Report and Opinion on the Safety of Gelatine, 2003 (www.europa.eu.int ).
14. T. Nemoto, M. Horiuchi, N. Ishiguro, and M. Shinagawa Arch. Virol. 144 1999 177 184
15. W. Beil, R. Timpl, and H. Furthmayr Immunology 24 1973 13 24
16. D. Michaeli, and E.H. Epstein Isr. J. Med. Sci. 7 1971 462 473